|
KMID : 0829320160190040088
|
|
Korean Journal of Clinical Microbiology
2016 Volume.19 No. 4 p.88 ~ p.96
|
|
|
Molecular Typing and Resistance Profiles of Vancomycin-Intermediate Staphylococcus aureus in Korea: Results from a National Surveillance Study, 2007-2013
|
|
Kim Jung-Wook
Kang Gi-Su
Yoo Jae-Il
Kim Hwa-Su
Lee Yeong-Seon
Yu Jae-Yon
Lee Kwang-Jun
Park Chan
Kim Il-Hwan
|
|
|
Abstract
|
|
|
Background: To investigate the national molecular epidemiology and resistance profiles of vancomycin- intermediate Staphylococcus aureus (VISA), we analyzed the characteristics of methicillin-resistant Staphylococcus aureus (MRSA) collected from clinical samples at tertiary or general hospitals participating in a nationwide surveillance program for VISA and vancomycin-resistant Staphylococcus aureus (VRSA) in Korea during an 12-week period in each year from 2007 to 2013.
Methods: VISA was defined by agar dilution, broth dilution and E-test methods with vancomycin minimum inhibitory concentrations of ＞2 μg/mL. All VISA isolates were characterized by multilocus sequence typing, staphylococcal cassette chromosome mec typing, spa typing, accessory gene regulatortyping, Diversilab analysis, and antibiogram analysis.
Results: Of 109,345 MRSA isolates, 87,354 were screened and 426 isolates were identified as positive on brain heart infusion agar containing 4 μg/mL vancomycin (BHI-V4). Of 426 isolates, 76 isolates were identified as VISA. No VRSA isolates were detected among the isolates. Overall, a total of 6 genotypes were identified among VISA strains and the predominant clones were ST5-II-t2460, ST72-IV-t324, and ST239-III-t037 (44.7%, 15.8%, and 10.5%, respectively). Of note, ST72-IV-t324 clones are known to be a typical community-associated MRSA. ST239-III- t037 strains were more resistant to trimethoprim-sulfamethoxazole than any other type of strain. ST72- IV-t324 strains were susceptible to all of the antimicrobial agents tested except erythromycin and daptomycin. All of the VISA isolates were susceptible to linezolid and quinupristin-dalfopristin.
Conclusion: Although VRSA is still rare, continuous monitoring of VRSA occurrence is needed, as well as VISA prevalence, epidemic clonal shift, and antimicrobial resistance.
|
|
|
KEYWORD
|
|
|
Sequence type, Vancomycin-intermediate Staphylococcus aureus
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|
|